✦ LIBER ✦

Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury:post hocanalysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

✍ Scribed by Yoram Kluger,Bruno Riou,Rolf Rossaint,Sandro B Rizoli…

Book ID: 126388358
Publisher: Springer (Biomed Central Ltd.)
Year: 2007
Tongue: English
Weight: 182 KB
Volume: 11
Category: Article
ISSN: 1466-609X
DOI: 10.1186/cc6092

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of esreboxetine in p

Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial

✍ Lesley M. Arnold; Ian Hirsch; Paul Sanders; Amanda Ellis; Bernadette Hughes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Efficacy and safety of risperidone in th

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial

✍ Dieter Naber; Andrew Greenspan; Andreas Schreiner 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 74 KB

Efficacy of a Complex Homeopathic Medica

Efficacy of a Complex Homeopathic Medication (Sinfrontal) in Patients with Acute Maxillary Sinusitis: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

✍ Dmitriy I. Zabolotnyi; Kyra C. Kneis; Andy Richardson; Reinhard Rettenberger; Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 268 KB

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

✍ Mohammad Ebrahim Parsanezhad; Saeed Alborzi; Bahia Namavar Jahromi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 131 KB

Efficacy and safety of pramipexole in ch

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: Results from a multi-center, randomized, double-blind, placebo-controlled trial

✍ Jian-Fang Ma; Qi Wan; Xin-Yue Hu; Sheng-Gang Sun; Wei-Zhi Wang; Zhong-Xin Zhao; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place